MEDIA

Press Releases

Main Menu
Select Year

FDA Approves Expanded Indication of DaxibotulinumtoxinA to Treat Cervical Dystonia

LEARN MORE

Daxxify Has Just Received FDA-Approval to Treat This Painful Neck Condition

LEARN MORE

Revance’s Botox rival gets FDA approval for painful neck muscle condition

LEARN MORE

Revance touts first therapeutic indication for Botox rival Daxxify in cervical dystonia

LEARN MORE

Revance touts first therapeutic indication for Botox rival Daxxify in cervical dystonia

LEARN MORE

Revance Wins First Daxxify Therapeutic Indication, Plans Limited Initial Rollout

LEARN MORE